Showing results (1-10 of 102) with videos related to
Sort By:
Pageof 11
Melanoma Research|April 13, 2012
Melanoma in the brain: biology and therapeutic optionsGeoffrey Thomas Gibney, Peter A Forsyth, Vernon K SondakTrends in Molecular Medicine|April 22, 2011
Immunotherapy in gliomas: limitations and potential of natural killer (NK) cell therapyHenry Ogbomo, Jindrich Cinatl, Christopher H Mody, et al.Cancer Control : Journal of the Moffitt Cancer Center|February 9, 2017
Experimental Treatments for Leptomeningeal Metastases From Solid MalignanciesSolmaz Sahebjam, Peter A Forsyth, Keiran S Smalley, et al.Journal of Neuro-Oncology|March 5, 2011
Leptomeningeal disease in oligodendroglial tumors: a population-based studyGloria Roldán, Jennifer Chan, Misha Eliasziw, et al.Cancers|March 29, 2023
Leptomeningeal Disease (LMD) in Patients with Melanoma MetastasesMariam Lotfy Khaled, Ahmad A Tarhini, Peter A Forsyth, et al.Journal of Neuro-Oncology|August 12, 2009
Use of peri-operative anti-epileptic drugs in patients with newly diagnosed high grade malignant glioma: a single center experienceShelly Lwu, Mark G Hamilton, Peter A Forsyth, et al.Cytokine & Growth Factor Reviews|May 21, 2010
Oncolytic viruses as experimental treatments for malignant gliomas: using a scourge to treat a devilFranz J Zemp, Juan Carlos Corredor, Xueqing Lun, et al.International Journal of Cancer|April 17, 2016
Managing leptomeningeal melanoma metastases in the era of immune and targeted therapyKeiran S M Smalley, Inna V Fedorenko, Rajappa S Kenchappa, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 25, 2023
A Brain, A Heart, and the Courage: Balancing Benefit and Toxicity of Immunotherapy in MelanomaYen-Chou Chen, Muhammad Jaffer, Lylybell Zhou, et al.Biochemical Pharmacology|December 27, 2017
The biology and therapeutic management of melanoma brain metastasesDaniel Abate-Daga, Maria C Ramello, Inna Smalley, et al.Pageof 11